Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 1
1983 1
1984 3
1985 1
1986 2
1987 6
1988 5
1989 6
1990 6
1991 7
1992 14
1993 1
1994 8
1995 13
1996 9
1997 13
1998 13
1999 20
2000 10
2001 10
2002 12
2003 11
2004 8
2005 11
2006 11
2007 10
2008 11
2009 14
2010 10
2011 16
2012 17
2013 21
2014 15
2015 24
2016 19
2017 13
2018 9
2019 12
2020 14
2021 9
2022 12
2023 8
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Results by year

Filters applied: . Clear all
Page 1
HIV.
Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. Ghosn J, et al. Among authors: autran b. Lancet. 2018 Aug 25;392(10148):685-697. doi: 10.1016/S0140-6736(18)31311-4. Epub 2018 Jul 23. Lancet. 2018. PMID: 30049419 Review.
Comment améliorer l’acceptabilité vaccinale (évaluation, pharmacovigilance, communication, santé publique, obligation vaccinale, peurs et croyances).
Dutilleul A, Morel J, Schilte C, Launay O; les participants à la table ronde « Sujet d’actualité (1) » des Ateliers de Giens XXXIV. Dutilleul A, et al. Therapie. 2019 Feb;74(1):119-129. doi: 10.1016/j.therap.2018.11.007. Epub 2018 Nov 27. Therapie. 2019. PMID: 30612731 French. No abstract available.
A truncated HIV Tat demonstrates potent and specific latency reversal activity.
Van Gulck E, Pardons M, Nijs E, Verheyen N, Dockx K, Van Den Eynde C, Battivelli E, Vega J, Florence E, Autran B, Archin NM, Margolis DM, Katlama C, Hamimi C, Van Den Wyngaert I, Eyassu F, Vandekerckhove L, Boden D. Van Gulck E, et al. Among authors: autran b. Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0041723. doi: 10.1128/aac.00417-23. Epub 2023 Oct 24. Antimicrob Agents Chemother. 2023. PMID: 37874295 Free PMC article.
iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.
Sbihi Z, Dossier A, Boutboul D, Galicier L, Parizot C, Emarre A, Hoareau B, Dupin N, Marcelin AG, Oudin A, Fieschi C, Agbalika F, Autran B, Oksenhendler E, Carcelain G. Sbihi Z, et al. Among authors: autran b. Blood. 2017 Feb 16;129(7):855-865. doi: 10.1182/blood-2016-06-719716. Epub 2016 Nov 9. Blood. 2017. PMID: 28060720 Free article.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
Immune control of HIV-1 reservoirs.
Autran B, Descours B, Bacchus C. Autran B, et al. Curr Opin HIV AIDS. 2013 May;8(3):204-10. doi: 10.1097/COH.0b013e32835fe6d2. Curr Opin HIV AIDS. 2013. PMID: 23493099 Review.
HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.
Rouers A, Klingler J, Su B, Samri A, Laumond G, Even S, Avettand-Fenoel V, Richetta C, Paul N, Boufassa F, Hocqueloux L, Mouquet H, Rouzioux C, Lambotte O, Autran B, Graff-Dubois S, Moog C, Moris A; ANRS CO21 Cohort. Rouers A, et al. Among authors: autran b. EBioMedicine. 2017 Jul;21:158-169. doi: 10.1016/j.ebiom.2017.05.029. Epub 2017 May 31. EBioMedicine. 2017. PMID: 28615147 Free PMC article.
HIV-1 therapeutic vaccines.
Kinloch-de Loes S, Autran B. Kinloch-de Loes S, et al. Among authors: autran b. J Infect. 2002 Apr;44(3):152-9. doi: 10.1053/jinf.2002.0987. J Infect. 2002. PMID: 12099741 Review.
421 results